AI
UTHR icon

Atom Investors’s United Therapeutics UTHR Stock Holding History

Atom Investors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.28M Sell
6,052
-5,209
-46% -$2.93M 0.29% 63
2026
Q1 		$6.68M Buy
+11,261
New +$5.61M 0.48% 39
2024
Q1 		– Sell
-5,649
Closed -$1.24M – 678
2023
Q4 		$1.24M Buy
5,649
+2,827
+100% +$652K 0.22% 156
2023
Q3 		$637K Buy
+2,822
New +$650K 0.15% 192
2022
Q1 		– Sell
-2,601
Closed -$562K – 321
2021
Q4 		$562K Buy
+2,601
New +$511K 0.09% 153
2021
Q2 		– Sell
-4,049
Closed -$677K – 338
2021
Q1 		$677K Sell
4,049
-7,110
-64% -$1.19M 0.11% 137
2020
Q4 		$1.69M Buy
+11,159
New +$1.46M 0.17% 147
2020
Q3 		– Sell
-20,020
Closed -$2.42M – 629
2020
Q2 		$2.42M Sell
20,020
-157,941
-89% -$17.8M 0.16% 118
2020
Q1 		$16.9M Buy
177,961
+24,255
+16% +$2.31M 1.48% 12
2019
Q4 		$13.5M Sell
153,706
-19,187
-11% -$1.69M 1.11% 25
2019
Q3 		$13.8M Buy
172,893
+131,415
+317% +$10.6M 0.94% 23
2019
Q2 		$3.24M Buy
41,478
+35,738
+623% +$3.34M 0.21% 140
2019
Q1 		$674K Buy
5,740
+2,506
+77% +$292K 0.06% 232
2018
Q4 		$352K Buy
+3,234
New +$375K 0.03% 460

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Atom Investors's UTHR Position: Q2 2026 in Review

Atom Investors reduced its United Therapeutics (UTHR) stake by 46% in Q2 2026, selling an estimated $2.93M and leaving 6,052 shares worth $3.28M. The position accounts for 0.29% of the portfolio, ranked #63.

Atom Investors first reported a position in UTHR in Q4 2018 and has held it in 14 quarters since. The position peaked at $16.9M in Q1 2020. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Atom Investors held 6,052 shares of United Therapeutics worth $3.28M as of Q2 2026.
  • Atom Investors sold 5,209 United Therapeutics shares in Q2 2026, an estimated $2.93M.
  • United Therapeutics made up 0.29% of Atom Investors's portfolio in Q2 2026, its #63 holding.
  • Atom Investors first reported a position in United Therapeutics in Q4 2018 and has held it in 14 quarters since.
  • Atom Investors's United Therapeutics position peaked at $16.9M in Q1 2020.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.